Director of Research in Statistics at Inria and Professor at the Centre for Applied Mathematics (CMAP*) at the École Polytechnique (IP Paris)
CEO at Lixoft
Personalised medicine produces a lot of data, some of which is not directly connected to the original intended analysis and can even include data relating to the patient’s family.
This raises questions on how to communicate this information and its value for the doctor, the patient, and society at large.
It is also very difficult to accurately assess all the cost vs. benefits of personalised healthcare.
Lastly, this new health model involves ethical considerations, to ensure that access to these new treatments is equitable.
After her initial studies in molecular biology, Agnès Vernet trained as a science journalist at ESJ-Lille. For the past 14 years, she has been writing for various media, scientific magazines, professional titles and general press, in France and Switzerland. Since 1st February 2021, she is the elected President of the French association of science journalists (AJSPI).